Stephen Beard Sells 3,545 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 3,545 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $130.34, for a total transaction of $462,055.30. Following the sale, the chief executive officer owned 415,197 shares in the company, valued at approximately $54,116,776.98. This trade represents a 0.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

CVSA stock traded up $3.98 during midday trading on Thursday, hitting $132.20. The stock had a trading volume of 267,402 shares, compared to its average volume of 371,319. The business has a 50-day moving average price of $125.00. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.45. The company has a market cap of $4.50 billion, a price-to-earnings ratio of 18.78, a PEG ratio of 0.94 and a beta of 0.62. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The company had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, sell-side analysts anticipate that Adtalem Global Education Inc. will post 8.99 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Truist Financial increased their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Barrington Research restated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Wall Street Zen raised shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Adtalem Global Education has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Institutional Investors Weigh In On Adtalem Global Education

An institutional investor recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management purchased a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by hedge funds and other institutional investors.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.